Cargando…
P1041: IMPACT OF FEDRATINIB ON SPLEEN VOLUME AND MYELOFIBROSIS SYMPTOMS IN PATIENTS WITH SUBSTANTIAL SPLENOMEGALY: POST HOC ANALYSES FROM THE JAKARTA AND JAKARTA2 TRIALS
| Autores principales: | , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429224/ http://dx.doi.org/10.1097/01.HS9.0000847032.10304.60 |
| _version_ | 1784779372660523008 |
|---|---|
| author | Kiladjian, J.-J. Tefferi, A. Passamonti, F. Vannucchi, A. Talpaz, M. Cervantes, F. Harrison, C. N. Mesa, R. A. Mascarenhas, J. Schaap, N. Verstovsek, S. Devos, T. Rose, S. Zhang, J. Sy, O. Pardanani, A. |
| author_facet | Kiladjian, J.-J. Tefferi, A. Passamonti, F. Vannucchi, A. Talpaz, M. Cervantes, F. Harrison, C. N. Mesa, R. A. Mascarenhas, J. Schaap, N. Verstovsek, S. Devos, T. Rose, S. Zhang, J. Sy, O. Pardanani, A. |
| author_sort | Kiladjian, J.-J. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9429224 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-94292242022-08-31 P1041: IMPACT OF FEDRATINIB ON SPLEEN VOLUME AND MYELOFIBROSIS SYMPTOMS IN PATIENTS WITH SUBSTANTIAL SPLENOMEGALY: POST HOC ANALYSES FROM THE JAKARTA AND JAKARTA2 TRIALS Kiladjian, J.-J. Tefferi, A. Passamonti, F. Vannucchi, A. Talpaz, M. Cervantes, F. Harrison, C. N. Mesa, R. A. Mascarenhas, J. Schaap, N. Verstovsek, S. Devos, T. Rose, S. Zhang, J. Sy, O. Pardanani, A. Hemasphere Posters Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9429224/ http://dx.doi.org/10.1097/01.HS9.0000847032.10304.60 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Kiladjian, J.-J. Tefferi, A. Passamonti, F. Vannucchi, A. Talpaz, M. Cervantes, F. Harrison, C. N. Mesa, R. A. Mascarenhas, J. Schaap, N. Verstovsek, S. Devos, T. Rose, S. Zhang, J. Sy, O. Pardanani, A. P1041: IMPACT OF FEDRATINIB ON SPLEEN VOLUME AND MYELOFIBROSIS SYMPTOMS IN PATIENTS WITH SUBSTANTIAL SPLENOMEGALY: POST HOC ANALYSES FROM THE JAKARTA AND JAKARTA2 TRIALS |
| title | P1041: IMPACT OF FEDRATINIB ON SPLEEN VOLUME AND MYELOFIBROSIS SYMPTOMS IN PATIENTS WITH SUBSTANTIAL SPLENOMEGALY: POST HOC ANALYSES FROM THE JAKARTA AND JAKARTA2 TRIALS |
| title_full | P1041: IMPACT OF FEDRATINIB ON SPLEEN VOLUME AND MYELOFIBROSIS SYMPTOMS IN PATIENTS WITH SUBSTANTIAL SPLENOMEGALY: POST HOC ANALYSES FROM THE JAKARTA AND JAKARTA2 TRIALS |
| title_fullStr | P1041: IMPACT OF FEDRATINIB ON SPLEEN VOLUME AND MYELOFIBROSIS SYMPTOMS IN PATIENTS WITH SUBSTANTIAL SPLENOMEGALY: POST HOC ANALYSES FROM THE JAKARTA AND JAKARTA2 TRIALS |
| title_full_unstemmed | P1041: IMPACT OF FEDRATINIB ON SPLEEN VOLUME AND MYELOFIBROSIS SYMPTOMS IN PATIENTS WITH SUBSTANTIAL SPLENOMEGALY: POST HOC ANALYSES FROM THE JAKARTA AND JAKARTA2 TRIALS |
| title_short | P1041: IMPACT OF FEDRATINIB ON SPLEEN VOLUME AND MYELOFIBROSIS SYMPTOMS IN PATIENTS WITH SUBSTANTIAL SPLENOMEGALY: POST HOC ANALYSES FROM THE JAKARTA AND JAKARTA2 TRIALS |
| title_sort | p1041: impact of fedratinib on spleen volume and myelofibrosis symptoms in patients with substantial splenomegaly: post hoc analyses from the jakarta and jakarta2 trials |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429224/ http://dx.doi.org/10.1097/01.HS9.0000847032.10304.60 |
| work_keys_str_mv | AT kiladjianjj p1041impactoffedratinibonspleenvolumeandmyelofibrosissymptomsinpatientswithsubstantialsplenomegalyposthocanalysesfromthejakartaandjakarta2trials AT tefferia p1041impactoffedratinibonspleenvolumeandmyelofibrosissymptomsinpatientswithsubstantialsplenomegalyposthocanalysesfromthejakartaandjakarta2trials AT passamontif p1041impactoffedratinibonspleenvolumeandmyelofibrosissymptomsinpatientswithsubstantialsplenomegalyposthocanalysesfromthejakartaandjakarta2trials AT vannucchia p1041impactoffedratinibonspleenvolumeandmyelofibrosissymptomsinpatientswithsubstantialsplenomegalyposthocanalysesfromthejakartaandjakarta2trials AT talpazm p1041impactoffedratinibonspleenvolumeandmyelofibrosissymptomsinpatientswithsubstantialsplenomegalyposthocanalysesfromthejakartaandjakarta2trials AT cervantesf p1041impactoffedratinibonspleenvolumeandmyelofibrosissymptomsinpatientswithsubstantialsplenomegalyposthocanalysesfromthejakartaandjakarta2trials AT harrisoncn p1041impactoffedratinibonspleenvolumeandmyelofibrosissymptomsinpatientswithsubstantialsplenomegalyposthocanalysesfromthejakartaandjakarta2trials AT mesara p1041impactoffedratinibonspleenvolumeandmyelofibrosissymptomsinpatientswithsubstantialsplenomegalyposthocanalysesfromthejakartaandjakarta2trials AT mascarenhasj p1041impactoffedratinibonspleenvolumeandmyelofibrosissymptomsinpatientswithsubstantialsplenomegalyposthocanalysesfromthejakartaandjakarta2trials AT schaapn p1041impactoffedratinibonspleenvolumeandmyelofibrosissymptomsinpatientswithsubstantialsplenomegalyposthocanalysesfromthejakartaandjakarta2trials AT verstovseks p1041impactoffedratinibonspleenvolumeandmyelofibrosissymptomsinpatientswithsubstantialsplenomegalyposthocanalysesfromthejakartaandjakarta2trials AT devost p1041impactoffedratinibonspleenvolumeandmyelofibrosissymptomsinpatientswithsubstantialsplenomegalyposthocanalysesfromthejakartaandjakarta2trials AT roses p1041impactoffedratinibonspleenvolumeandmyelofibrosissymptomsinpatientswithsubstantialsplenomegalyposthocanalysesfromthejakartaandjakarta2trials AT zhangj p1041impactoffedratinibonspleenvolumeandmyelofibrosissymptomsinpatientswithsubstantialsplenomegalyposthocanalysesfromthejakartaandjakarta2trials AT syo p1041impactoffedratinibonspleenvolumeandmyelofibrosissymptomsinpatientswithsubstantialsplenomegalyposthocanalysesfromthejakartaandjakarta2trials AT pardanania p1041impactoffedratinibonspleenvolumeandmyelofibrosissymptomsinpatientswithsubstantialsplenomegalyposthocanalysesfromthejakartaandjakarta2trials |